Log In
Print
BCIQ
Print
Print this Print this
 

CL-108

  Manage Alerts
Collapse Summary General Information
Company Charleston Laboratories Inc.
DescriptionBilayered tablet containing 12.5 mg immediate-release promethazine, an anti-emetic, with 7.5 mg hydrocodone and 325 mg acetaminophen
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe acute pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today